Avita Medical (RCEL) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

RCEL Avita Medical

Watchlist

11.770
+0.290+2.53%

Close Dec 20 16:00 ET

11.770
0.0000.00%

Post 16:09 ET

308.58MMarket Cap-5.28P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Lake Street Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $20
Moomoo NewsDec 20 14:31 ET · Ratings
Lake Street Gives a Buy Rating to Avita Medical (RCEL)
TipRanksDec 20 13:39 ET · Ratings
AVITA Medical Gets FDA Clearance for Wound Treatment; Shares Rise After Hours
MT NewswiresDec 19 17:59 ET
Express News | AVITA Medical Inc - to Develop Clinical Data for Cohealyx in Early 2025
ReutersDec 19 17:05 ET
Express News | AVITA Medical Announces FDA 510(K) Clearance for Cohealyx, Expanding Its Addressable Market
ReutersDec 19 17:05 ET
Why Is AVITA Medical Inc. (RCEL) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?
Yahoo FinanceDec 10 22:37 ET

Comments

Jaguar8

Dec 19 17:46

🟢 Watchlist FRIDAY December 20,2024. N F A !

NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits
5. Always remember shorts include dark pools.
6. Most importantly, don’t blame for your losses. I already give watchlist and stock education. The ball is on you.
7. I DO NOT give buy or sell advice
8. COH (cash on hand); AH (after hours): RTH (regular trading hours)
$Aadi Biosciences (AADI.US)$ PR AH 12/...

Jaguar8

Dec 19 16:05

NEWS

$Avita Medical (RCEL.US)$
AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market
Thursday, 19th December at 5:05 pm
New collagen-based dermal matrix designed for tissue generation, complementary to RECELL and PermeaDerm
Cohealyx expected to triple AVITA Medical's addressable market in burns
VALENCIA, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH)), a commercial-stage regenerative medicine company focused on first-in...

Jaguar8

May 30 08:16

NEWS

$Avita Medical (RCEL.US)$
AVITA Medical Announces FDA Approval of RECELL GO
AVITA Medical announced FDA approval for its advanced autologous cell harvesting device, RECELL GO. This next-gen device improves treatment for thermal burn wounds and full-thickness skin defects by harnessing a patient's own skin. Key advantages include faster healing, reduced pain, improved aesthetics, and fewer procedures. Enhanced features streamline the preparation of Spray-On Skin Cells and improve workflow effi...

Moomoo AI

Jan 21 15:54

Cantor Fitzgerald sees AVITA's superior growth and high gross margins as reasons for a premium. The firm also sees potential in Pacific Biosciences and AxoGen, and expects positive share price appreciation for Exagen and NeuroPace. A significant catalyst for Nyxoah's stock is anticipated with upcoming DREAM study data.

Cantor Picks RCEL as Best 2024 Medtech Idea; Bullish on PACB, AXGN, CERS

Moomoo AI

Jan 10 08:09

AVITA Medical's CEO, Jim Corbett, is satisfied with the company's growth and is committed to sustaining it in 2024. The ongoing TONE study could influence future business strategies by providing insights into vitiligo's impact on patients' mental health and healthcare costs.